The course and prognosis of different forms of chronic airways obstruction in a sample from the general population - PubMed (original) (raw)
The course and prognosis of different forms of chronic airways obstruction in a sample from the general population
B Burrows et al. N Engl J Med. 1987.
Abstract
We examined the course and prognosis in subjects selected from the general population who had chronic airflow obstruction at the time of their enrollment in a longitudinal epidemiologic study. Mortality and the rate of change in lung function were analyzed in relation to the initial clinical characteristics of the subjects. Twenty-seven subjects with symptoms and signs of asthma (Group I) had a higher survival rate and a much lower rate of decline in pulmonary function than the 45 subjects in Group III, whose clinical characteristics were more compatible with an emphysematous form of chronic obstructive pulmonary disease (COPD). The 10-year mortality among subjects in Group III (non-atopic smokers without a history of asthma) was close to 60 percent, whereas it was only 15 percent in Group I (atopic subjects or nonsmokers with known asthma). The mean overall rate of decline in forced expiratory volume in one second was 70 ml per year in Group III but less than 5 ml per year in Group I. Forty-five patients (Group II) who did not clearly fit into either Group I or III had intermediate values for survival and decline in pulmonary function. Previous data on mortality from COPD and the rate of progression of the condition, although compatible with our findings in patients who had an emphysematous form of disease, are not applicable to those with an asthmatic-bronchitic form. Better control of the progression of asthmatic bronchitis with therapy may explain its more favorable prognosis.
Similar articles
- Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up.
Contoli M, Baraldo S, Marku B, Casolari P, Marwick JA, Turato G, Romagnoli M, Caramori G, Saetta M, Fabbri LM, Papi A. Contoli M, et al. J Allergy Clin Immunol. 2010 Apr;125(4):830-7. doi: 10.1016/j.jaci.2010.01.003. Epub 2010 Mar 15. J Allergy Clin Immunol. 2010. PMID: 20227753 - A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group.
Kerstjens HA, Brand PL, Hughes MD, Robinson NJ, Postma DS, Sluiter HJ, Bleecker ER, Dekhuijzen PN, de Jong PM, Mengelers HJ, et al. Kerstjens HA, et al. N Engl J Med. 1992 Nov 12;327(20):1413-9. doi: 10.1056/NEJM199211123272003. N Engl J Med. 1992. PMID: 1357553 Clinical Trial. - [Course of obstructive lung diseases].
Bakke PS. Bakke PS. Tidsskr Nor Laegeforen. 1993 Jan 20;113(2):177-81. Tidsskr Nor Laegeforen. 1993. PMID: 8430396 Review. Norwegian. - Prognosis in chronic obstructive pulmonary disease.
Hodgkin JE. Hodgkin JE. Clin Chest Med. 1990 Sep;11(3):555-69. Clin Chest Med. 1990. PMID: 2205443 Review.
Cited by
- Heterogeneity and Progression of Chronic Obstructive Pulmonary Disease: Emphysema-Predominant and Non-Emphysema-Predominant Disease.
Castaldi PJ, Xu Z, Young KA, Hokanson JE, Lynch DA, Humphries SM, Ross JC, Cho MH, Hersh CP, Crapo JD, Strand M, Silverman EK. Castaldi PJ, et al. Am J Epidemiol. 2023 Oct 10;192(10):1647-1658. doi: 10.1093/aje/kwad114. Am J Epidemiol. 2023. PMID: 37160347 Free PMC article. - Acoustic Monitoring of Night-Time Respiratory Symptoms in 14 Patients with Exacerbated COPD Over a 3- Week Period.
Boeselt T, Kroenig J, Lueders TS, Koehler N, Beutel B, Hildebrandt O, Koehler U, Conradt R. Boeselt T, et al. Int J Chron Obstruct Pulmon Dis. 2022 Nov 18;17:2977-2986. doi: 10.2147/COPD.S377069. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36425059 Free PMC article. - The disconnect between visual assessment of air trapping and lung physiology for assessment of small airway disease in scleroderma-related interstitial lung disease: An observation from the Scleroderma Lung Study II Cohort.
Bae SS, Pourzand L, Hyun Kim G, Villegas BE, Oh A, Furst DE, Goldin J, Tashkin DP. Bae SS, et al. J Scleroderma Relat Disord. 2022 Jun;7(2):117-127. doi: 10.1177/23971983211047160. Epub 2021 Oct 23. J Scleroderma Relat Disord. 2022. PMID: 35585954 Free PMC article. - Lung Function Decline in Adult Asthmatics-A 10-Year Follow-Up Retrospective and Prospective Study.
Bucchieri S, Alfano P, Audino P, Cibella F, Fazio G, Marcantonio S, Cuttitta G. Bucchieri S, et al. Diagnostics (Basel). 2021 Sep 7;11(9):1637. doi: 10.3390/diagnostics11091637. Diagnostics (Basel). 2021. PMID: 34573977 Free PMC article. - Red blood cell distribution width and serum CA-125 level as prognostic markers in acute exacerbation of chronic obstructive pulmonary disease.
He F, Zhao P, Chu Y, Zhao N, Cheng J. He F, et al. J Int Med Res. 2021 May;49(5):3000605211020229. doi: 10.1177/03000605211020229. J Int Med Res. 2021. PMID: 34057839 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical